Nectar Lifesciences Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 19,258.32 million compared to INR 17,465.57 million a year ago. Revenue was INR 16,986.61 million compared to INR 15,668.48 million a year ago.

Net income was INR 49.95 million compared to net loss of INR 241.83 million a year ago. Basic earnings per share from continuing operations was INR 0.22 compared to basic loss per share from continuing operations of INR 1.08 a year ago. Diluted earnings per share from continuing operations was INR 0.22 compared to diluted loss per share from continuing operations of INR 1.08 a year ago.